Inventor
BYUNGJE SUNG
Inventor
KR
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
PatentTitleYear
12,577,313Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof202612,195,537Anti-4-1BB antibody and use thereof202512,122,830Anti-ROR1 antibody and use thereof202412,071,483Bispecific antibody to alpha-synuclein/insulin-like growth factor 1 receptor and use thereof202412,049,493Anti-alpha-synuclein antibodies and uses thereof202411,891,445Anti-B7-H3 antibody and use thereof202411,707,533Antibody-drug conjugate comprising antibody against human ROR1 and use for the same202311,261,259Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to ABL BIO INC (8)· patent assignee history
2022–2026Patents assigned to I MAB BIOPHARMA US LTD (2)· patent assignee history
2022–2026Based in KR· patent location history
2023Patents assigned to LEGOCHEM BIOSCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABL BIO INC | 8 | 2022–2026 |
| I MAB BIOPHARMA US LTD | 2 | 2022–2026 |
| LEGOCHEM BIOSCIENCES INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 8 | 2022–2026 |